Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Blood - United States
doi 10.1182/blood.v124.21.1522.1522
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology


Related search